Valuation: Xiamen Kingdomway Group Company

Market Cap 10.23B 1.53B 1.38B 1.28B 1.15B 2.18B 144B 2.24B 15.29B 6.09B 76.97B 5.75B 5.63B 245B P/E 2026 *
24.6x
P/E 2027 * 17.2x
Enterprise Value 10.23B 1.53B 1.38B 1.28B 1.15B 2.18B 144B 2.24B 15.29B 6.09B 76.97B 5.75B 5.63B 245B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.15x
Free-Float
39.49%
Yield 2026 *
2.56%
Yield 2027 * 3.96%
1 day-0.23%
1 week+0.29%
Current month-1.94%
1 month+7.99%
3 months+4.25%
6 months+6.58%
Current year-12.94%
1 week 16.91
Extreme 16.91000000
18
1 month 14.98
Extreme 14.98
19.19
Current year 12.9
Extreme 12.9
20.81
1 year 12.9
Extreme 12.9
21.52
3 years 10.71
Extreme 10.71
22.44
5 years 10.71
Extreme 10.71
33.91
10 years 10.71
Extreme 10.71
64.48
Manager TitleAgeSince
Chief Executive Officer 59 2010-04-17
Director of Finance/CFO 44 2016-04-11
Corporate Officer/Principal 62 2013-04-09
Director TitleAgeSince
Chairman 59 1997-10-31
Director/Board Member 62 2001-06-12
Director/Board Member 44 2019-04-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+0.29%-18.09%-3.92% 1.53B
-0.58%+0.01%+5.72%-13.55% 269B
+0.24%-1.01%+16.77%-3.50% 84.23B
-0.38%+0.62%-13.83%+18.63% 49.01B
+1.43%+1.11%+2.15%-7.86% 34.96B
+2.34%+0.11%+23.06%-2.18% 32.98B
-2.40%-4.89%-10.45%-9.78% 30.29B
-1.70%-2.73%+8.28%+11.23% 29.48B
+0.12%-4.60%-1.62%-26.21% 28.7B
-1.00%+3.21%+1.76%+6.52% 26.7B
Average -0.22%+0.76%+1.37%-3.06% 59B
Weighted average by Cap. -0.30%+1.58%+5.13%-6.68%

Financials

2026 *2027 *
Net sales 3.76B 563M 507M 469M 424M 802M 52.8B 822M 5.62B 2.24B 28.28B 2.11B 2.07B 90B 4.76B 713M 643M 594M 537M 1.02B 66.9B 1.04B 7.12B 2.84B 35.83B 2.68B 2.62B 114B
Net income 424M 63.49M 57.22M 52.86M 47.79M 90.41M 5.95B 92.64M 634M 253M 3.19B 238M 233M 10.15B 609M 91.28M 82.27M 76.01M 68.71M 130M 8.56B 133M 911M 363M 4.59B 343M 335M 14.59B
Net Debt - -
Projected Income Statement - Annual - Xiamen Kingdomway Group Company
Logo Xiamen Kingdomway Group Company
Xiamen Kingdomway Group Co is a China-based company principally engaged in the research and development, production and sales of nutritional health foods (including raw materials and end products) and feed additives. The Company's raw materials include coenzyme Q10, Docosahexaenoic Acid (DHA), Arachidonic Acid (ARA), vitamin A, vitamin D3, vitamin K2, nattokinase, pyrroloquinoline quinone (PQQ), Nicotinamide Mononucleotide (NMN), astaxanthin, inositol series products and others. The feed additives produced by the Company include vitamin A, vitamin D3 and others. The Company also produces pharmaceutical raw materials such as praziquantel, alanylglutamine, and oxiracetam. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
2,184
Date Price Change Volume
26-11-11 CN¥17.16 -0.23% 5,925,108
26-11-10 CN¥17.20 -1.26% 6,488,600
26-11-09 CN¥17.42 -0.17% 10,023,500
26-11-06 CN¥17.45 -0.63% 11,725,900
26-11-05 CN¥17.56 -3.09% 15,180,300
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Xiamen Kingdomway Group Company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
17.16CNY
Average target price
23.02CNY
Spread / Average Target
+34.17%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Xiamen Kingdomway Group Company
  1. Stock Market
  2. Stocks
  3. 002626 Stock